Utility of Mannitol and Citric Acid for Enhancing the Solubilizing and Taste Masking Properties of β-Cyclodextrin: Development of Fast-Dissolving Tablets Containing Extremely Bitter Drug

Battu SK, Repka MA, Majumdar S, Madhusudan RY. Formulation and evaluation of rapidly disintegrating fenoverine tablets: effect of superdisintegrants. Drug Dev Ind Pharm. 2007;33(11):1225–32.

Hanawa T, Watanabe A, Tsuchiya T, Ikoma R, Hidaka M, Sugihara M. New oral dosage form for elderly patients: preparation and characterization of silk fibroin gel. Chem Pharm Bull (Tokyo). 1995;43(2):284–8.

Khan S, Kataria P, Nakhat P, Yeole P. Taste masking of ondansetron hydrochloride by polymer carrier system and formulation of rapid-disintegrating tablets. AAPS PharmSciTech. 2007;8(2):127–33.

Mady FM, Abou-Taleb AE, Khaled KA, Yamasaki K, Iohara D, Taguchi K, et al. Evaluation of carboxymethyl-beta-cyclodextrin with acid function: improvement of chemical stability, oral bioavailability and bitter taste of famotidine. Int J Pharm. 2010;397(1–2):1–8.

Soni T, Chirag N, Tejal G, Chotai NP. Development of discriminating method for dissolution of aceclofenac marketed formulations. Dissolut Technol. 2008;5:31–5.

Maulvi FA, Dalwadi SJ, Thakkar VT, Soni TG, Gohel MC, Gandhi TR. Improvement of dissolution rate of aceclofenac by solid dispersion technique. Powder Technol. 2011;207(1–3):47–54.

Carrier RL, Miller LA, Ahmed I. The utility of cyclodextrins for enhancing oral bioavailability. J Control Release. 2007;123(2):78–99.

Ranpise NS, Kulkarni NS, Mair PD, Ranade AN. Improvement of water solubility and in vitro dissolution rate of aceclofenac by complexation with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin. Pharm Dev Technol. 2010;15(1):64–70.

Dua K, Pabreja K, Ramana MV, Lather V. Dissolution behavior of beta-cyclodextrin molecular inclusion complexes of aceclofenac. J Pharm Bioallied Sci. 2011;3(3):417–25.

Valero M, Perez-Revuelta BI, Rodriguez LJ. Effect of PVP K-25 on the formation of the naproxen:beta-ciclodextrin complex. Int J Pharm. 2003;253(1–2):97–110.

Basalious EB, El-Sebaie W, El-Gazayerly O. Rapidly absorbed orodispersible tablet containing molecularly dispersed felodipine for management of hypertensive crisis: development, optimization and in vitro/in vivo studies. Pharm Dev Technol. 2013;18(2):407–16.

Abdelbary A, Elshafeey AH, Zidan G. Comparative effects of different cellulosic-based directly compressed orodispersable tablets on oral bioavailability of famotidine. Carbohydr Polym. 2009;77(4):799–806.

Setty CM, Prasad D, Gupta V, Sa B. Development of fast dispersible aceclofenac tablets: effect of functionality of superdisintegrants. Indian J Pharm Sci. 2008;70(2):180.

British Pharmacopeia, Electronic Version 17, Crown Copyright 2012.

Miyamoto Y, Nakahara M, Motoyama K, Ishiguro T, Oda Y, Yamanoi T, et al. Improvement of some physicochemical properties of arundic acid, (R)-(−)-2-propyloctanonic acid, by complexation with hydrophilic cyclodextrins. Int J Pharm. 2011;413(1–2):63–72.

GalenIQ Grades, http://www.beneo-palatinit.com/en/Pharma_Excipients/galenIQ/galenIQ_Grades/galenIQ721/ . Accessed 25 Jan 2014.

High Functionality Excipient, PROSOLV® SMCC, http://www.jrs.de/jrs_en/life-science/jrs-pharma-excipients/produkte/prosolv-smcc/index.php . Accessed on 8 Aug 2014.

PEARLITOL® mannitol, http://www.roquette-pharma.com/pearlitol-mannitol-direct-compression-effervescent-tablets-diluent/# . Accessed 8 Aug 2014.

Jha SK, Vijayalakshmi P, Karki R, Goli D. Formulation and evaluation of melt-in-mouth tablets of haloperidol. Asian J Pharm. 2008;2(4):255.

Sammour OA, Hammad MA, Megrab NA, Zidan AS. Formulation and optimization of mouth dissolve tablets containing rofecoxib solid dispersion. AAPS PharmSciTech. 2006;7(2):E55.

Kasliwal N, Negi JS. Development, characterization and performance evaluation of oro-dispersible tablet containing aceclofenac hydroxypropyl-bcyclodextrin binary system. J Incl Phenom Macrocycl Chem. 2011;71:215–24.

Gonnissen Y, Remon JP, Vervaet C. Effect of maltodextrin and superdisintegrant in directly compressible powder mixtures prepared via co-spray drying. Eur J Pharm Biopharm. 2008;68(2):277–82.

Szejtli J, Szente L. Elimination of bitter, disgusting tastes of drugs and foods by cyclodextrins. Eur J Pharm Biopharm. 2005;61(3):115–25.

Rawat S, Jain SK. Enhancement of intestinal absorption of few COX-2 inhibitors through interaction with β-cyclodextrin. Indian J Pharm Sci. 2007;69:529–34.

Guyot M, Fawaz F, Bildet J, Bonini F, Lagueny AM. Physicochemical characterization and dissolution of norfloxacin/cyclodextrin inclusion compounds and PEG solid dispersions. Int J Pharm. 1995;123(1):53–63.

Mutalik S, Naha A, Usha AN, Ranjith AK, Musmade P, Manoj K, et al. Preparation, in vitro, preclinical and clinical evaluations of once daily sustained release tablets of aceclofenac. Arch Pharm Res. 2007;30(2):222–34.